Summary of Significant Accounting Policies - Revenue Recognition (Details)	3 Months Ended
Mar. 31, 2026 performanceObligation
Revenue Recognition
Collaboration revenue, percentage	50.00%
Biogen \| Clinical Supply Agreement
Revenue Recognition
Number of performance obligations	1

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration